The Role of Interleukin-6 in Castleman Disease

Authors

Keywords

Interleukin-6, Humanized anti-IL-6 receptor antibody, Tocilizumab, Chimeric anti-IL-6 antibody, Siltuximab, Multicentric Castleman disease, IL-6 blocking therapy

Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Volume 32, Issue 1, Pages 23-36

Publisher

Elsevier BV

Online

2017-11-18

DOI

10.1016/j.hoc.2017.09.003

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started